in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
API business of Dr. Reddy’s reports fall in sales
10:51 AM MST | February 11, 2014 | Deepti Ramesh
The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 29% fall in sales in the company’s fiscal third quarter, ended 31 December 2013, compared with the year-ago quarter, to 5.06 billion Indian rupees ($81 million). Earnings figures for the PSAI business have not been disclosed. During the quarter, 19 drug master files (DMF) were filed globally, including 6 in Europe, Dr. Reddy’s says. As of 31 December 2013, the cumulative DMF filings were 612. Europe accounted for about...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee